Invesco Global Shareholder Yield ETF (PSY) Quote

Not a recommendation for you!

https://assets.amuniversal.com/0fa58f900ee1013d5a15005056a9545d

Multiple patients have now exceeded 30 weeks on treatment
Boston ( June 25 , 2024)—Allarity Therapeutics, Inc. (“Allarity” or the “Company”) (NASDAQ: ALLR), a Phase 2 clinical-stage pharmaceutical company dedicated to developing personalized cancer treatments, today announced that multi

........but the Oilers did look really gassed there at the end so it still might have not turned out like I wanted with another period.

Like Kane and Toews on their last legs. A two superstar team couldn't quite pull it off.

$RJDG Chart - #UnderValued
https://www.barchart.com/stocks/quotes/RJDG/overview#google_vignette

BLULLISH Re: Top Penny post# 32113

https://x.com/FashionDiva1990/status/1805420125010465194

RGS w t ph

It feels like it will be June 28 - 30

for IDE submission at this point.
On Friday or this weekend.

But it could still be any day now.
Even today.

Haha, yep.

I have no legal knowledge at all, however, and this is just my guess interpretation. " [114] Voluntary Dismissal of Third-Party Complaint" Maybe this means this court nonsense has come to an end and TMMI can begin to do something constructive. Again, I have no clue.

I am very bullish on AUTR, it is getting very thin for shares, I hope some people sell!!!

https://assets.amuniversal.com/81e001300fd9013d5a7c005056a9545d

Your response tells me you are very scared. I know it is Canadian behaving like a clasic OTC con game, lol lol lol
GLTY

FYI Mr Kissinger :) Magnum7419 47 seconds ago

His achievements will surely be remembered for a lunchtime.

Oh, okay, I was exaggerating!

Morning Watch List : https://www.optionmillionaires.com/june-25th-2024-watch-list/

This Pump?

https://investorshub.advfn.com/uimage/uploads/2023/8/5/wpm[kposter_Stock_Barber_on_ihub_to.png

Easy to see $KEGS is a winner —

https://nyibeercompetition.com/winners/

$$$KEGS$$$

I'm sure Peanut will give the birthday girl a few nuggets!!!!

(Oh, wth, it's worth the beaking!)

FYI Mr Kissinger :)

Boston ( June 25 , 2024)—Allarity Therapeutics, Inc. (“Allarity” or the “Company”) (NASDAQ: ALLR), a Phase 2 clinical-stage pharmaceutical company dedicated to developing personalized cancer treatments, today announced that multiple patients in its Phase 2 clinical trial of stenoparib for advanced

GLYC $.44 do your DD